1α-hydroxyvitamin D3 suppresses trabecular bone resorption by inhibiting osteoclastogenic potential in bone marrow cells after ovariectomy in mice

Journal of Bone and Mineral Metabolism

Volumn 19, Issue 5, 2001, Pages 277-286

  Sakai, Akinori ^a   Nishida, Satoshi ^a   Nishida, Shigeki ^a   Tsutsui, Takao ^b   Takeuchi, Kazuya ^a   Takeda, Satoshi ^c   Nakamura, Toshitaka ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

1 hydroxyvitamin D3; Bone marrow; Osteoclastogenesis; Ovariectomy; RANKL

Indexed keywords

CALCITRIOL; 1-HYDROXYCHOLECALCIFEROL; ALFACALCIDOL; ALKALINE PHOSPHATASE; CARRIER PROTEIN; CELL RECEPTOR; GLYCOPROTEIN; HYDROXYCOLECALCIFEROL; MEMBRANE PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, MOUSE; TNFRSF11B PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MINERALIZATION; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; TIBIA; TRABECULAR BONE; ANIMAL; BLOOD ANALYSIS; CLONOGENIC ASSAY; CYTOLOGY; GENETICS; METABOLISM; METHODOLOGY; MOUSE; MOUSE STRAIN; OSTEOCLAST;

ALKALINE PHOSPHATASE; ANIMALS; BLOOD CHEMICAL ANALYSIS; BONE MARROW CELLS; BONE RESORPTION; CARRIER PROTEINS; COLONY-FORMING UNITS ASSAY; FEMALE; GLYCOPROTEINS; HYDROXYCHOLECALCIFEROLS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; OSTEOCLASTS; OSTEOPROTEGERIN; OVARIECTOMY; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TIBIA;

EID: 0034741829     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007740170011     Document Type: Article

References (35)

1. Bone marrow cell development and trabecular bone dynamics after ovariectomy in ddy mice
2. Local bone turnover in the metaphysis of the proximal tibia and the lumbar vertebra during the early periods after ovariectomy in rats
3. 3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women
4. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis
5. Prevention of early postmenopausal bone loss: Controlled 2-year study in 315 normal females
6. The importance of genetic and nutritional factors in responses to vitamin D and its analogs in osteoporotic patients
7. The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype
8. 2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats
9. Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats
10. 3 analogs on osteoporosis caused by ovariectomy in rats
11. 3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats
12. 3
13. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet
14. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: Distinct actions from estrogen
15. Ovariectomy and orchidectomy induce a transient increase in the osteoclastogenic potential of bone marrow cells in the mouse
16. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
17. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
18. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
19. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis
20. Bone marrow capacity for bone cells and trabecular bone turnover in immobilized tibia after sciatic neurectomy
21. Bone histomorphometry: Standardization of nomenclature, symbols, and units
22. Relationship between surface, volume and thickness of iliac trabecular bone in aging and osteoporosis: Implications for the microanatomic and cellular mechanisms of bone loss
23. Bone formation in vitro by stromal cells obtained from bone marrow of young rats
24. Bone marrow from mechanically unloaded rat bones expresses reduced osteogenic capacity in vitro
25. Basic fibroblast growth factor enhances the capacity of bone marrow cells to form bone-like nodules in vitro
26. Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: Enhanced development of mineralized bone-like tissue in culture
27. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures
28. Intermittent administration of human parathyroid hormone (1-34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice
29. Trabecular bone turnover and bone marrow cell development in tail-suspended mice
30. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
31. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
32. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation
33. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
34. 2 induces expression of receptor activator of nuclear factor-κB ligand/osteoprotegrin ligand on pre-B cells: Implications for accelerated osteoclastogenesis in estrogen deficiency
35. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction